Skip to main content

Your Partner for International Pharmaceutical Growth

We connect pharmaceutical manufacturers and commercialisation organisations with the markets they deserve to reach. Our focus is the United Kingdom, Europe, the Middle East, Greater China and other selected global markets.

WHAT WE DO

Specialists in International Pharmaceutical Commercialisation

Navigating complex pharmaceutical markets requires more than just expertise, it takes the right partner. At Lexigen, we pair deep specialty pharma insights with an established international network to guide healthcare organisations through the world's most challenging landscapes.

International Commercialisation

We support market entry across international territories, from initial strategy through licensing, partner identification, and launch.

Market Access and Regulatory Coordination

We coordinate licensing, regulatory pathway planning, and market access strategy to help products reach the patients who need them.

Strategic Supply and Distribution

We connect manufacturers with qualified distribution partners and support compliant cross-border supply across all our key regions.

Licensing and Product Development

We are building our own portfolio of specialty pharmaceutical products through strategic in-licensing and selective development partnerships.

THERAPEUTIC FOCUS

Areas Where We Have Deep Expertise

Our team brings specialist knowledge across therapeutic areas where international market access is particularly complex.

CNS and Mental Health

CNS and Mental Health

Specialty medicines for neurological and psychiatric conditions

Oncology

Oncology

Targeted therapies and supportive care products

Rare and Orphan Diseases

Rare and Orphan Diseases

Specialist products with complex regulatory pathways

Immunology

Immunology

Biologics and small molecules for autoimmune indications

Biologics and Biosimilars

Biologics and Biosimilars

Complex biologics, monoclonal antibodies, and biosimilar programmes

Specialty Pharmaceuticals

Specialty Pharmaceuticals

Niche products including those in development and in-licensing

THE BARRIERS WE REMOVE

International Markets Are Complex. We Make Them Navigable.

Every pharmaceutical market has its gatekeepers. Regulatory requirements, language barriers, reimbursement frameworks, and cultural dynamics all slow things down for organisations without the relevant local knowledge and relationships. Lexigen exists to help from both sides.

Entering UK and European Markets

Barriers

  • English-language regulatory submissions for MHRA and EMA

  • Separate post-Brexit pathways for UK and EU registration

  • NICE and national HTA reimbursement requirements

  • NHS procurement and regional formulary access

  • GDP-compliant distribution and CD & cold chain requirements

  • Stringent pharmacovigilance obligations

How Lexigen helps

  • Established network of UK and EU specialty pharma partners with products available for B2B

  • Regulatory knowledge across MHRA and EMA, including post-Brexit navigation

  • Market access experience across NHS, NICE, and EU payer frameworks

  • Qualified distribution partner network for compliant supply

  • English-language dossier coordination and partner liaison

Entering China and GCC Markets

Barriers

  • NMPA registration complexity and timelines of three to seven years or more

  • Mandatory Chinese-language dossiers and labelling

  • Legal requirement for a registered local agent in China

  • Separate Ministry of Health registrations across each GCC state

  • Arabic labelling requirements and relationship-based commercial culture

  • Import licensing, quota management, and customs compliance

How Lexigen helps

  • Established commercial relationships and partner networks across Greater China and GCC

  • Local agent and commercial partner introductions for China market entry

  • GCC registration coordination across multiple Ministry of Health systems

  • Arabic-language documentation and local labelling support

  • Regional pricing and reimbursement guidance

  • Long-term relationship investment in both regions

Lexigen brings the networks, the regulatory knowledge, and the commercial relationships to clear these barriers. So your team can focus on what it does best.

WHY LEXIGEN

A Partner That Has Been There Before

Our leadership team combines close to two decades of specialty pharmaceutical experience across global markets with senior operational expertise from world-leading technology organisations.

Deep Roots, Wide Reach

Close to 20 years of specialty pharma experience across the UK, Europe, the Middle East, Australia, and Canada. This includes close collaboration with EU and India CDMOs, and established networks of manufacturers, distributors, and regulatory partners across all key regions.

Built on Relationships

We operate on trust and long-term thinking, not transactional deal-making. Every partnership starts with the same principle: your success is our success. We only take on relationships we genuinely believe in.

End-to-End Expertise

We understand the full product lifecycle from R&D and regulatory affairs through supply chain, market access, and commercialisation. That perspective helps us add value and spot problems at any point in the journey.

Commercially Aligned

Our models are designed to be flexible and commercially sustainable for all parties. We think in outcomes. Our Dubai base gives us a well-connected international platform across the regions we serve.

Let's Build Something Together

You may be a manufacturer looking to commercialise a new dossier, an international company seeking a trusted UK and European partner, or a licence holder exploring strategic growth opportunities. Whatever your situation, we would welcome the conversation.

info@lexigenhealthcare.com

We aim to respond to all enquiries within two business days.